Nabla Raises $70M to Advance Agentic AI in Clinical Care, Expand Nationwide Impact
Nabla, a fast-growing provider of AI assistants for healthcare, has raised $70 million in Series C funding, pushing its total raise to $120 million. The round was led by HV Capital, with Highland Europe, DST Global, Cathay Innovation, and Build Collective also participating. The funding fuels Nabla’s mission to embed agentic AI directly into clinical workflows, transforming how providers document care and interact with electronic health records (EHRs).
Nabla’s assistant is now deployed across 130+ healthcare organizations, including CVS Health, Denver Health, and Children’s Hospital Los Angeles, supporting over 85,000 clinicians and powering more than 20 million annual encounters.
From Documentation to Action: The Rise of the Agentic Clinical Assistant
Initially focused on reducing clinician documentation burden, Nabla is now evolving into a proactive, agentic AI platform that adapts to clinical workflows and initiates real-time EHR actions. The next phase of the platform introduces advanced features, including:
- Proactive Coding Agent: Enhancing support for ICD-10, HCC, and MCC coding with forthcoming compliance tools for E/M documentation.
- Context-Aware Agent: Leveraging historical data for smarter summaries, initiating orders, and streamlining pre-charting.
- Custom Care Setting Agent: Expanding support to nurses, inpatient care, and other frontline roles through tailored interfaces and workflows.
“We’re moving beyond documentation,” said Alex Lebrun, CEO and co-founder. “Nabla is building toward an adaptive AI assistant that not only listens but acts—transforming how clinical care is delivered at scale.”
Trusted at Scale: Delivering Measurable Impact Across Healthcare Systems
Backed by peer-reviewed studies and real-world performance metrics, Nabla reports:
- 50%+ reduction in documentation time
- Significant drops in clinician burnout
- 15-point improvement in patient satisfaction
Designed with a privacy-first architecture, Nabla integrates seamlessly with Epic, Cerner, athenahealth, and other major EHR platforms. The assistant supports 35+ languages and is widely adopted in rural hospitals, FQHCs, and children’s hospitals, where clinician efficiency is mission-critical.
Built on a domain-specific LLM, Nabla processes 30+ billion tokens per month, enabling continuous optimization and fine-tuning of medical language tasks.
Why It Matters
Nabla’s momentum reflects a broader shift in clinical AI—from passive transcription tools to intelligent, action-oriented agents embedded in care delivery. With health systems under pressure to improve efficiency, reduce burnout, and scale services, Nabla offers a blueprint for human-AI collaboration in high-stakes environments.
“What Nabla has built is extraordinary,” said Alexander Joel-Carbonell, Partner at HV Capital. “The platform’s adoption rate, trust from clinicians, and clinical-grade accuracy position it as a category leader in healthcare AI.”
The Road Ahead
The new capital will support:
- Product development of Nabla’s Adaptive Agentic Platform
- Expansion into new care settings, including inpatient and nursing workflows
- Strategic partnerships to scale nationally and globally
- Hiring across technical, clinical, and go-to-market teams
With hands-on support and a flexible rollout process, Nabla is consistently chosen over competitors in side-by-side pilots—earning top marks for usability, deployment speed, and clinician satisfaction.
“It’s rare to see technology adopted this rapidly across an academic health system,” said Dr. James Blum, CHIO at University of Iowa Physicians. “Nabla’s responsiveness and integration into our workflows make it an indispensable partner.”
Power Tomorrow’s Intelligence — Build It with TechEdgeAI.
